ZOLGENSMA

Google image searchProduct monograph

Active ingredient

onasemnogene abeparvovec, 20000000000000 VG/ML

DIN: 02509695

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 04-FEB-2021

ATC:

• M09 — OTHER DRUGS FOR DISORDERS OF THE MUSCULOSKELETAL SYSTEM (ATC, ATC/DDD, )
• M09A — OTHER DRUGS FOR DISORDERS OF THE MUSCULOSKELETAL SYSTEM (ATC, ATC/DDD)
• M09AX — Other drugs for disorders of the musculo-skeletal system (ATC, ATC/DDD)
• M09AX09 — ONASEMNOGENE ABEPARVOVEC (ATC/DDD)

Pharmaceutical standard: MFR

External Links for Zolgensma

Search on Google

• Zolgensma side effects
• Zolgensma dosage
• onasemnogene abeparvovec side effects
• onasemnogene abeparvovec dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find zolgensma photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.